Immunovant, Inc. IMVT Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total loss before income taxes by Geography | ||||||
| Bermuda | -$9.75K0.0% | -$9.75K0.0% | -$9.75K0.0% | -$9.75K+61.0% | -$25K0.0% | |
| Switzerland | -$151.57M0.0% | -$151.57M0.0% | -$151.57M0.0% | -$151.57M-53.4% | -$98.78M0.0% | |
| United Kingdom | -$13.75K0.0% | -$13.75K0.0% | -$13.75K0.0% | -$13.75K— | $0— | |
| United States | $25.25M0.0% | $25.25M0.0% | $25.25M0.0% | $25.25M+670% | -$4.43M0.0% | |
| Net operating loss carry forwards by Geography | ||||||
| Switzerland | $279M— | —— | —— | —— | $1.09B— | |
| United States | $195.2M— | —— | —— | —— | $48.7M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Immunovant, Inc. break its business down?
- Immunovant, Inc. (IMVT) reports total loss before income taxes by geography across 4 parts — Bermuda, Switzerland, United Kingdom and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Immunovant, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Immunovant, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.